Horst Buerger

10.9k total citations · 1 hit paper
112 papers, 7.8k citations indexed

About

Horst Buerger is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Horst Buerger has authored 112 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 38 papers in Oncology and 37 papers in Cancer Research. Recurrent topics in Horst Buerger's work include Breast Lesions and Carcinomas (20 papers), Cancer and Skin Lesions (19 papers) and Cancer Genomics and Diagnostics (18 papers). Horst Buerger is often cited by papers focused on Breast Lesions and Carcinomas (20 papers), Cancer and Skin Lesions (19 papers) and Cancer Genomics and Diagnostics (18 papers). Horst Buerger collaborates with scholars based in Germany, Netherlands and United States. Horst Buerger's co-authors include Burkhard Brandt, Werner Boecker, Nicola Tidow, Wolfgang E. Berdel, P. J. van Diest, Hubert Serve, Carsten Müller‐Tidow, Michael Thomas, Etmar Bulk and Sebastian Böing and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Biomaterials.

In The Last Decade

Horst Buerger

110 papers receiving 7.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer

2003 1.8k citations Ping Ji, Sven Diederichs et al. Oncogene profile →

Peers

Countries citing papers authored by Horst Buerger

Since Specialization

Citations

This map shows the geographic impact of Horst Buerger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Horst Buerger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Horst Buerger more than expected).

Fields of papers citing papers by Horst Buerger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Horst Buerger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Horst Buerger. The network helps show where Horst Buerger may publish in the future.

Co-authorship network of co-authors of Horst Buerger

This figure shows the co-authorship network connecting the top 25 collaborators of Horst Buerger. A scholar is included among the top collaborators of Horst Buerger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Horst Buerger. Horst Buerger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Re-Operation Rate for Breast Conserving Surgery Using Confocal Histolog Scanner for Intraoperative Margin Assessment—SHIELD Study 2025 ·Cancers ·Michael P. Lux, (unknown), (unknown), (unknown), Christian Kersting, Horst Buerger, (unknown)	0
2	Site-specific gene expression patterns in oral cancer 2017 ·Head & Face Medicine ·Gesche Frohwitter, Horst Buerger, Eberhard Korsching, P. J. van Diest, Johannes Kleinheinz, Thomas Fillies	22
3	Cytokeratin and protein expression patterns in squamous cell carcinoma of the oral cavity provide evidence for two distinct pathogenetic pathways 2016 ·Oncology Letters ·Gesche Frohwitter, Horst Buerger, P. J. van Diest, Eberhard Korsching, Johannes Kleinheinz, Thomas Fillies	29
4	Immunophenotyping of male breast cancer 2012 ·Histopathology ·Robert Kornegoor, Anoek H J Verschuur‐Maes, Horst Buerger, M. C. H. Hogenes, Peter C. de Bruin, Joost J. Oudejans, Bernd Hinrichs, P. J. van Diest	26
5	Influence of whole arm loss of chromosome 16q on gene expression patterns in oestrogen receptor‐positive, invasive breast cancer 2011 ·The Journal of Pathology ·D. Hungermann, H Schmidt, Rachael Natrajan, Nicola Tidow, (unknown), Jorge S. Reis‐Filho, Burkhard Brandt, Horst Buerger, Eberhard Korsching	27
6	TOB1 Is Regulated by EGF-Dependent HER2 and EGFR Signaling, Is Highly Phosphorylated, and Indicates Poor Prognosis in Node-Negative Breast Cancer 2009 ·Cancer Research ·Mike W. Helms, Dirk Kemming, Christopher H. Contag, Heike Pospisil, Kai Bartkowiak, Alice Wang, Sheng-Yung Chang, Horst Buerger, Burkhard Brandt	33
7	CD44 is overexpressed in basal-like breast cancers but is not a driver of 11p13 amplification 2009 ·Breast Cancer Research and Treatment ·Pamela Klingbeil, Rachael Natrajan, (unknown), Radost Vatcheva, Caterina Marchiò, José Palacios, Horst Buerger, Jorge S. Reis‐Filho, Clare M. Isacke	51
8	In vitro chemosensitivity testing in invasive breast cancer: Increased sensitivity of the basal subtype is not independent of the tumor proliferation rate 2006 ·Clinical Cancer Research ·Cornelia Liedtke, Jens Packeisen, H Schmidt, Eberhard Korsching, (unknown), Burkhard Brandt, Ludwig Kiesel, Horst Buerger	1
9	High incidence of metastatic disease in primary high grade and large extremity soft tissue sarcomas treated without chemotherapy 2006 ·BMC Cancer ·Benedikt Leidinger, Thomas J. Heyse, Andreas Schuck, Horst Buerger, Philipp Mommsen, Thomas Bruening, Susanne Fuchs, Georg Gosheger	3
10	Intestinal cancer in patients with Crohn’s disease 2006 ·International Journal of Colorectal Disease ·(unknown), Matthias Bruewer, Mike G. Laukoetter, (unknown), Rudolf Mennigen, Horst Buerger, N. Senninger, Christian F. Krieglstein	26
11	Cox-2 and Her2/neu co-expression in invasive bladder cancer 2005 ·International Journal of Oncology ·Elke Eltze, Christian Wülfing, (unknown), Hansjürgen Piechota, Horst Buerger, L. Hertle	46
12	Adenomyoepithelial tumours and myoepithelial carcinomas of the breast – a spectrum of monophasic and biphasic tumours dominated by immature myoepithelial cells 2005 ·BMC Cancer ·D. Hungermann, Horst Buerger, C. Oehlschlegel, Hermann Herbst, Werner Boecker	41
13	Gene dosage PCR and fluorescence in situ hybridization reveal low frequency of egfr amplifications despite protein overexpression in invasive breast carcinoma 2004 ·Laboratory Investigation ·Christian Kersting, Nicola Tidow, H Schmidt, Cornelia Liedtke, (unknown), Werner Boecker, P. J. van Diest, Burkhard Brandt, Horst Buerger	65
14	Different proliferative activity of the glandular and myoepithelial lineages in benign proliferative and early malignant breast diseases 2004 ·Modern Pathology ·Ágnes Bánkfalvi, A. Ludwig, (unknown), Horst Buerger, Igor Buchwalow, Werner Boecker	39
15	Expression of the p14ARF tumor suppressor predicts survival in acute myeloid leukemia 2004 ·Leukemia ·Carsten Müller‐Tidow, (unknown), Horst Buerger, Jens Packeisen, (unknown), Gerhard Heil, (unknown), (unknown), Joachim Schwäble, Björn Steffen, WD Ludwig, Achim Heinecke, Th. Büchner, Wolfgang E. Berdel, Hubert Serve	24
16	MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer breakdown → 2003 ·Oncogene ·Ping Ji, Sven Diederichs, Wenbing Wang, Sebastian Böing, Ralf Metzger, Paul M. Schneider, Nicola Tidow, Burkhard Brandt, Horst Buerger, Etmar Bulk, Michael Thomas, Wolfgang E. Berdel, Hubert Serve, Carsten Müller‐Tidow	1844
17	Early placenta insulin-like growth factor (pro-EPIL) is overexpressed and secreted by c-erbB-2-positive cells with high invasion potential. 2002 ·PubMed ·Burkhard Brandt, (unknown), Jean‐Michel Bidart, Jens Packeisen, (unknown), (unknown), Dirk Kemming, Werner Boecker, Dihua Yu, Horst Buerger	20
18	Cytogenetic Alterations and Cytokeratin Expression Patterns in Breast Cancer: Integrating a New Model of Breast Differentiation into Cytogenetic Pathways of Breast Carcinogenesis 2002 ·Laboratory Investigation ·Eberhard Korsching, Jens Packeisen, Konstantin Agelopoulos, Martin Eisenacher, Reinhard Voß, Jorma Isola, P. J. van Diest, Burkhard Brandt, Werner Boecker, Horst Buerger	208
19	Analysis of the progression of fibroepithelial tumours of the breast by PCR‐based clonality assay 2002 ·The Journal of Pathology ·Arno Kuijper, Horst Buerger, Ronald Simon, Karl‐Ludwig Schaefer, (unknown), Werner Boecker, Elsken van der Wall, P. J. van Diest	61
20	A common progenitor (adult stem) cell gives rise to both the glandular and myoepithelial cell lineages. a new cell biological concept as the basis of breast pathology 2001 ·Breast Cancer Research and Treatment ·Werner Boecker, R. Moll, (unknown), P. Dervan, Horst Buerger, Burkhard Brandt, Robert E. Holland, Christopher Poremba, Raihanatou Diallo, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact